Form 4: UnitedHealth Group Executive Patrick Conway Granted Significant Equity Awards

Patrick Hugh Conway, CEO of Optum, a UnitedHealth Group subsidiary, has been granted 1,641 restricted stock units and 6,550 non-qualified stock options, aligning his interests with the company's long-term performance.

Summary

• Patrick Hugh Conway, Chief Executive Officer of Optum, a subsidiary of UnitedHealth Group Inc. (UNH), was granted equity awards.
• On June 2, 2025, Mr. Conway acquired 1,641 shares of Common Stock in the form of restricted stock units (RSUs) at a price of $0 per share.
• These RSUs will vest at a rate of 25% annually on June 2 from 2026 through 2029.
• Following this transaction, Mr. Conway beneficially owns 11,815.251 shares of Common Stock.
• Additionally, on June 2, 2025, Mr. Conway was granted 6,550 non-qualified stock options with an exercise price of $304.72 per option.
• These stock options also vest at a rate of 25% annually on June 2 from 2026 through 2029 and expire on June 2, 2035.
• After this grant, Mr. Conway beneficially owns 6,550 non-qualified stock options.

Sentiment

Score: 8

Explanation: The grant of significant equity awards to a key executive is a strong positive signal, indicating alignment of interests and confidence in future performance. While not a direct market purchase, it reflects a commitment to long-term value creation.

Positives

• The grant of restricted stock units and non-qualified stock options to a key executive like Patrick Conway indicates a strong commitment to aligning management's interests with shareholder value.
• The vesting schedule over several years (2026-2029) encourages long-term performance and retention of the executive.
• The acquisition of additional equity by a high-ranking officer is generally viewed as a positive signal of confidence in the company's future prospects.

Future Outlook

This Form 4 filing primarily reports an executive's equity compensation and does not provide forward-looking statements or guidance regarding the company's financial performance or strategic outlook.

Industry Context

This filing is specific to an individual executive's compensation within UnitedHealth Group and does not directly reflect broader industry trends. However, executive equity grants are a common practice across the healthcare and managed care sectors to incentivize leadership and align their performance with shareholder returns.

Stakeholder Impact

• **Shareholders**: The equity grant aligns the interests of a key executive with shareholders, potentially leading to better long-term performance and value creation.
• **Employees**: May signal stability in leadership and a commitment to retaining key talent within the organization.
• **Management**: Provides significant long-term incentives for Patrick Conway, linking his compensation directly to the company's stock performance.

Next Steps

• The restricted stock units and non-qualified stock options will begin vesting annually on June 2, starting in 2026 and concluding in 2029.
• Patrick Conway will continue to hold these equity instruments, subject to the specified vesting schedule and terms.

Key Dates

Recommendation

Keywords

UnitedHealth Group, UNH, Patrick Conway, Optum, SEC Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Equity Grant, Executive Compensation, Healthcare, Managed Care